Night Squared LP raised its holdings in Xylem Inc. (NYSE:XYL – Free Report) by 12.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 45,325 shares of the industrial products company’s stock after acquiring an additional 5,080 shares during the quarter. Xylem comprises 1.7% of Night Squared LP’s portfolio, making the stock its 29th largest position. Night Squared LP’s holdings in Xylem were worth $6,172,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Norges Bank bought a new stake in shares of Xylem in the 4th quarter valued at $361,012,000. Schroder Investment Management Group increased its position in shares of Xylem by 2,055.2% in the 3rd quarter. Schroder Investment Management Group now owns 1,192,682 shares of the industrial products company’s stock valued at $171,687,000 after buying an additional 1,137,342 shares in the last quarter. Balyasny Asset Management L.P. increased its position in shares of Xylem by 346.2% in the 3rd quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock valued at $105,160,000 after buying an additional 553,152 shares in the last quarter. Adage Capital Partners GP L.L.C. bought a new stake in shares of Xylem in the 2nd quarter valued at $64,407,000. Finally, Jennison Associates LLC increased its position in shares of Xylem by 241.6% in the 4th quarter. Jennison Associates LLC now owns 633,648 shares of the industrial products company’s stock valued at $86,290,000 after buying an additional 448,148 shares in the last quarter. 87.96% of the stock is owned by institutional investors.
Xylem Trading Up 1.1%
Shares of NYSE:XYL opened at $112.19 on Wednesday. Xylem Inc. has a 12 month low of $105.29 and a 12 month high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. The company’s fifty day simple moving average is $115.39 and its 200 day simple moving average is $126.83. The firm has a market cap of $26.67 billion, a price-to-earnings ratio of 27.91, a PEG ratio of 1.58 and a beta of 1.04.
Xylem announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, February 25th that allows the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization allows the industrial products company to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its shares are undervalued.
Xylem Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Thursday, May 28th will be issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date is Thursday, May 28th. Xylem’s dividend payout ratio (DPR) is presently 42.79%.
Insiders Place Their Bets
In other Xylem news, Director Jerome A. Peribere purchased 1,210 shares of the stock in a transaction on Monday, May 4th. The shares were purchased at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the purchase, the director owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.32% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms recently commented on XYL. Jefferies Financial Group restated a “hold” rating and issued a $130.00 price objective (down from $140.00) on shares of Xylem in a research report on Tuesday, March 31st. Weiss Ratings cut shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th. JPMorgan Chase & Co. lowered their price objective on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, April 16th. Citigroup lowered their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. Finally, UBS Group upped their price objective on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Seven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $152.77.
View Our Latest Research Report on XYL
About Xylem
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Articles
- Five stocks we like better than Xylem
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
